The contract research organisation industry in the recession ? a CRO Frost report
May 5, 2010 by biotechconnection.com · Leave a Comment
According to a recent report carried out by Frost and Sullivan, the CRO industry will continue to expand despite speculation resultant of the volatile economic climate we have recently experienced. In this climate, biotechnology and pharmaceutical companies avoid investing in in-house capabilities for the conduct of their research studies and in turn rely tend to [...]
Brand Principles Introduces Latest Market Research Report on Gpcr – Drug Targets
May 5, 2010 by biotechconnection.com · Leave a Comment
BrandPrinciples.com has been working on various market research reports pertaining to biotechnology which is there expertise and thus, concentrate only on this industry which is growing at a high speed. These unique research reports are of immense value to investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools.
This [...]
National Bioscience Report Shows Some Growth Even During Recession
May 5, 2010 by biotechconnection.com · Leave a Comment
National Bioscience Report Shows Some Growth Even During Recession
CHICAGO, IL–(Marketwire – 05/03/10) – The U.S. bioscience industry continued to score employment gains through 2008 — the first year of the recent economic downturn, according to a study released today by Battelle and the Biotechnology Industry Organization (BIO). The Battelle/BIO State Bioscience Initiatives 2010 contains the [...]
Parexel International Corporation – Swot Analysis – Aarkstore Enterprise Market Reserach Report
May 2, 2010 by biotechconnection.com · Leave a Comment
PAREXEL International Corporation – SWOT Analysis company profile is the essential source for top-level company data and information. PAREXEL International Corporation – SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
PAREXEL International (PAREXEL) is a biopharmaceutical services company [...]
New Report On Stem Cell Therapeutics Markets Added In Visionshopsters
May 1, 2010 by biotechconnection.com · Leave a Comment
Political and business events presage change for stem cell therapeutics, most notably the expected move by President Barack Obama to lift federal funding restrictions on stem-cell research. The U.S. Congress has also indicated a desire to move forward with stem cell research. The momentum in two branches of American government, along with scientific developments and [...]